Previous 10 | Next 10 |
2023-08-14 16:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-10 16:38:11 ET The US Supreme Court in December will hear arguments in a case that will examine the legality of a $6B bankruptcy settlement that shields Purdue Pharma's Sackler family from further exposure over its role in the nation's opioid crisis. In an order , the High C...
2023-08-02 13:01:38 ET Teva Pharmaceutical ( NYSE: TEVA ) CEO Richard Francis said the company has no current plans to separate its brands and generics businesses. "Right now, we don't see the value in that," Francis told CNBC in an interview on Wednesday. "Right now we have a l...
2023-08-02 12:47:07 ET Teva Pharmaceutical Industries Limited (TEVA) Q2 2023 Earnings Conference Call August 2, 2023, 8:00 a.m. ET Company Participants Richard Francis - President & CEO Eli Kalif - CFO Dr. Eric Hughes - CMO, Head of R&D Sven Dethlefs ...
2023-08-02 11:05:30 ET Summary Teva Pharmaceutical operates globally, offering affordable health solutions through its portfolio of generic medicines, over-the-counter products, and innovative drugs. The company faces challenges such as patent expiration and competition but shows ...
2023-08-02 11:00:24 ET Image source: The Motley Fool. Teva Pharmaceutical Industries (NYSE: TEVA) Q2 2023 Earnings Call Aug 02, 2023 , 8:00 a.m. ET Operator Continue reading For further details see: Teva Pharmaceutical Industries (TEVA) Q...
2023-08-02 10:26:22 ET More on Teva Pharmaceutical Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story Teva Pharmaceutical: Lacking Capabilities For Strategic Investments Teva Pharmaceutical: New Growth Plan Could Restore Investor Confidence Seek...
2023-08-02 10:17:25 ET Gainers: TRxADE HEALTH ( MEDS ) +60% . Armata Pharmaceuticals ( ARMP ) +17% . Teva Pharmaceutical Industries ( TEVA ) +13% . CareDx ( CDNA ) +9% . Mallinckrodt ( MNK ) +9% . Losers: Adamis Pharmaceut...
2023-08-02 09:28:37 ET Wall Street's stock index futures on Wednesday pointed to a lower open, as market participants digested a surprise U.S. rating downgrade from Fitch. Traders also parsed through the latest ADP jobs report along with a Treasury refunding announcement. Here are some stoc...
2023-08-02 07:59:40 ET More on Teva Pharmaceutical Teva Pharmaceutical's Remarkable Growth In 2023: A Success Story Teva Pharmaceutical: Lacking Capabilities For Strategic Investments Teva Pharmaceutical: New Growth Plan Could Restore Investor Confidence Seek...
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
Teva Pharmaceutical Industries Limited American Depositary Shares Website:
SPACE pediatric Phase 3 study met its primary end point for efficacy with a significantly greater reduction in Monthly Migraine Days compared to placebo Efficacy is consistent with AJOVY (fremanezumab) pivotal Phase 3 and Real-World Evidence studies in adults with no new emerg...
2024-07-10 08:00:08 ET Ashwani Verma from UBS issued a price target of $24.00 for TEVA on 2024-07-10 07:20:00. The adjusted price target was set to $24.00. At the time of the announcement, TEVA was trading at $15.81. The overall price target consensus is at $15.00 with h...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8...